Market Research Logo

Slovakia Pharmaceuticals & Healthcare Report Q2 2018

Slovakia Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Expenditure within Slovakia's pharmaceutical market will come under increasing scrutiny as healthcare funding remainsinsufficient. Increased rhetoric towards the use of OTC medicines and enforcement of generic substitution policies will limitpatented drugmaker opportunities, leading to underperformance relative to its neighbours. This all means revenue challenges formultinational pharmaceutical firms.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Market Forecast
Industry Risk/Reward Index
Risk/Reward Index
Risk/Reward Index
Regulatory Development
Regulatory Landscape
Market Overview
Competitive Landscape
Company Profile
HBM Pharma
Imuna Pharma
Demographic Forecast
Demographic Outlook 2017
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report